AIFA
- Local brand name: Attrogy
- Status: approved
Dolobid (DIFLUNISAL) regulatory status in Italy.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. AIFA has authorised it.
Marketing authorisation holder not available in our data.